Peer-reviewed Publications

Zhu, et al. 2020 Cell Stem Cell:

Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-Tumor Activity

Zhu, et al. 2020 Blood:

Pluripotent Stem Cell–Derived NK Cells with High-Affinity Noncleavable CD16a Mediate Improved Antitumor Activity

Zhu, et al. 2019 Method in Molecular Biology:

An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells

Li, et al. 2018 Cell Stem Cell:

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity

Yamamoto, et al. 2020 ASH:

ADAM17-Deficient Pluripotent Stem Cell-Derived Natural Killer Cells Possess Improved Antibody-Dependent Cellular Cytotoxicity and Antitumor Activity

Goldenson, et al. 2020 Frontiers in Immunology:

Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles

Knorr, et al. 2013 Stem Cells Translational Medicine:

Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy


Zhu, et al. 2018 Stem Cells:

Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy

Wang, et al. 2019 Expert Opinion on Biological Therapy:

The Rise of Human Stem Cell-Derived Natural Killer Cells for Cancer Immunotherapy

Bernareggi, et al. 2019 Experimental Hematology:

Development of Innate Immune Cells from Human Pluripotent Stem Cells